Medwave edición Octubre 2016

Medwave edición agosto 2016 Vea este email en su navegador

---------------------  Contenidos recientemente publicados:  --------------------------- REPORTE DE CASO Pancreatitis recurrente secundaria a disfunción del esfínter de Oddi: presentación de un caso Jeannette Calzadilla, Natalia Sanhueza, Solange Farías, Félix González (Chile) Medwave 2016;16(9):e6585 Rara asociación de anoftalmía, malformación cardíaca compleja e hipertensión pulmonar: reporte de caso Raul Enrique Rios-Mendez, Michell Marola Lozano Chinga (Ecuador) Medwave 2016 Oct;16(9):e6568 CARTAS A LA EDITORA   Papel de los medios de comunicación sobre la percepción social del trabajo médico en el Perú y Latinoamérica Isabel Silva-Ocas, Kevin Lemus-Arteaga, Jaime Gonzales-Saldaña, Jose Galvez-Olortegui, Tomas Galvez-Olortegui (Perú) medwave 2016;16(9):e6586 Revistas latinoamericanas de psicología indexadas en Scopus Julio Cjuno, Alvaro Taype-Rondan (Perú) medwave 2016;16(9):6579 Indicadores cienciométricos de Medwave en Scopus y desafíos futuros Carlos Acosta-Batista, Rosali Mullings-Pérez (Cuba) Medwave 2016 Oct;16(9):e6575 Envío de manuscritos originales http://ojs.medwave.cl/index.php/medwave/login ------------------------------------------------ Instrucciones a los autores http://www.medwave.cl/link.cgi/instrucciones.act ----------------------------------------------------------------- Si quiere participar como par revisor de Medwave http://www.medwave.cl/link.cgi/revisor.act ------------------------------------------------------------------ Contacto con la revista: Rodrigo Núñez publishing@medwave.cl

Camios epigenetics por el modo de nacimiento y alimentacion con Leche Materna

Estimado Ciberpediatra te invito al Seminario de Pediatría, Cirugía Pediátrica y Lactancia Materna. El día 5 de Octubre 2016 las 21hrs (Centro, México DF, Guadalajara y Lima Perú) a la Conferencia: “Camios epigenetics por el modo de nacimiento y alimentacion con Leche Materna”, por el Dr. “Jorge Alfredo Lomelí Meillon”, Pediatra de la Cd de Culiacán Sin. La sesión inicia puntualmente las 21 hrs.
Para entrar a la Sala de Conferencia:
1.- hacer click en la siguiente liga, o cópiala y escríbela en tu buscador
http://connectpro60196372. adobeconnect.com/epigenetica_ lm/
2.- “Entra como Invitado” Escribes tu nombre y apellido en el espacio en blanco
3.- Hacer click en el espacio que dice “Entrar en la Sala”
5.- A disfrutar la conferencia
6.- Recomendamos que dejes tu Nombre Completo, Correo electrónico y que participes.Henrys



-

Dr. Enrique Mendoza López
Webmaster: CONAPEME
Coordinador Nacional: Seminario Ciberpeds-Conapeme
Av La Clinica 2520-310 col Sertoma
Monterrey N.L. CP 64718
Tel (81) 83482940, (81) 83485701
Cel 0448183094806
www.pediatramendoza.com
www.conapeme.org
www.ciberpeds.org

Anestesia pediátrica / Pediatric anesthesia

Octubre 3, 2016. No. 2467

Propofol. Revisión de su papel en anestesia y sedación pediátrica Propofol: a review of its role in pediatric anesthesia and sedation. Chidambaran V1, Costandi A, D'Mello A. CNS Drugs. 2015 Jul;29(7):543-63. doi: 10.1007/s40263-015-0259-6. Abstract Propofol is an intravenous agent used commonly for the induction and maintenance of anesthesia, procedural, and critical care sedation in children. The mechanisms of action on the central nervous system involve interactions at various neurotransmitter receptors, especially the gamma-aminobutyric acid A receptor. Approved for use in the USA by the Food and Drug Administration in 1989, its use for induction ofanesthesia in children less than 3 years of age still remains off-label. Despite its wide use in pediatric anesthesia, there is conflicting literature about its safety and serious adverse effects in particular subsets of children. Particularly as children are not "little adults", in this review, we emphasize the maturational aspects of propofol pharmacokinetics. Despite the myriad of propofol pharmacokinetic-pharmacodynamic studies and the ability to use allometrical scaling to smooth out differences due to size and age, there is no optimal model that can be used in target controlled infusion pumps for providing closed loop total intravenous anesthesia in children. As the commercial formulation of propofol is a nutrient-rich emulsion, the risk for bacterial contamination exists despite the Food and Drug Administration mandating addition of antimicrobial preservative, calling for manufacturers' directions to discard open vials after 6 h. While propofol has advantages over inhalation anesthesia such as less postoperative nausea and emergence delirium in children, pain on injection remains a problem even with newer formulations. Propofol is known to depress mitochondrial function by its action as an uncoupling agent in oxidative phosphorylation. This has implications for children with mitochondrial diseases and the occurrence of propofol-related infusion syndrome, a rare but seriously life-threatening complication of propofol. At the time of this review, there is no direct evidence in humans for propofol-induced neurotoxicity to the infant brain; however, current concerns of neuroapoptosis in developing brains induced by propofol persist and continue to be a focus of research. PDF Inducción con barbituratos para prevenir agitación en la emergencia anestésica con sevoflurano Barbiturate Induction for the Prevention of Emergence Agitation after Pediatric Sevoflurane Anesthesia. Use T1, Nakahara H1, Kimoto A1, Beppu Y1, Yoshimura M1, Kojima T2, Fukano T1. J Pediatr Pharmacol Ther. 2015 Sep-Oct;20(5):385-92. doi: 10.5863/1551-6776-20.5.385. Abstract OBJECTIVES: Emergence agitation (EA) is a common and troublesome problem in pediatric patients recovering from general anesthesia. The incidence of EA is reportedly higher after general anesthesia maintained with sevoflurane, a popular inhalational anesthetic agent for pediatricpatients. We conducted this prospective, randomized, double-blind study to test the effect of an intravenous ultra-short-acting barbiturate, thiamylal, administered during induction of general anesthesia on the incidence and severity of EA in pediatric patients recovering from Sevoflurane anesthesia. METHODS: Fifty-four pediatric patients (1 to 6 years of age) undergoing subumbilical surgeries were randomized into 2 groups. Patients received either intravenous thiamylal 5mg/kg (Group T) or inhalational Sevoflurane 5% (Group S) as an anesthetic induction agent. Following induction, general anesthesia was maintained with Sevoflurane and nitrous oxide (N2O) in both groups. To control the intra- and post-operative pain, caudal block or ilioinguinal/iliohypogastric block was performed. The incidence and severity of EA were evaluated by using the Modified Objective Pain Scale (MOPS: 0 to 6) at 15 and 30 min after arrival in the post-anesthesia care unit (PACU). RESULTS: Fifteen minutes after arrival in the PACU, the incidence of EA in Group T (28%) was significantly lower than in Group S (64%; p = 0.023) and the MOPS in Group T (median 0, range 0 to 6) was significantly lower than in Group S (median 4, range 0 to 6; p = 0.005). The interval from discontinuation of Sevoflurane to emergence from anesthesia was not significantly different between the 2 groups. CONCLUSIONS: Thiamylal induction reduced the incidence and severity of EA in pediatric patients immediately after Sevoflurane anesthesia. KEYWORDS: Sevoflurane; anesthesia recovery period; pediatrics; psychomotor agitation; thiamylal PDF Comparación entre sevoflorano y tiopental como inductores y agitación postanestésica en pacientes pediátricos A comparison of postoperative emergence agitation between sevoflurane and thiopental anesthesia induction in pediatric patients. Son JS1, Jang E1, Oh MW1, Lee JH1, Han YJ1, Ko S1. Korean J Anesthesiol. 2015 Aug;68(4):373-8. doi: 10.4097/kjae.2015.68.4.373. Epub 2015 Jul 28. Abstract BACKGROUND: This study was performed to compare the incidence of emergence agitation (EA) between inhalation and intravenous anesthesiainduction in children after sevoflurane anesthesia. METHODS: In this prospective and double-blind study, 100 children aged 3 to 7 years were enrolled. Subjects were randomly assigned to the sevoflurane (Group S) or thiopental (Group T) anesthesia induction groups. Anesthesia was induced using 8% sevoflurane and 4-6 mg/kg thiopental in Groups S and T, respectively. Anesthesia was maintained with nitrous oxide and sevoflurane. The children were evaluated at 5 and 20 min after arrival in the postanesthesia care unit (PACU) with a four-point agitation scale and the Pediatric Anesthesia Emergence Delirium scale. The incidence of EA and administration of the rescue agent were recorded. RESULTS: The incidence of EA was significantly lower in Group T compared to Group S at 5 min after PACU arrival (3/49 patients, 6% vs. 12/47 patients, 26%, P = 0.019). However, there was no difference between the two groups at 20 min after PACU arrival (23/49 vs. 19/47 patients in Group T vs. Group S, P = 0.425). The overall incidence of EA was 60% (28/47 patients) in Group S and 41% (20/49 patients) in Group T (P = 0.102). The number of children who received propofol as a rescue agent was significantly lower in Group T (Group S: 14/47 vs. Group T: 5/49, P = 0.031). CONCLUSIONS: Intravenous anesthesia induction with thiopental reduced the incidence of EA in the early PACU period compared to inhalation induction with sevoflurane in 3- to 7-year-old children undergoing sevoflurane anesthesia. KEYWORDS: Agitation; Pediatrics; Sevoflurane; Thiopental PDF XIII Congreso Virtual Mexicano de Anestesiología Octubre a Diciembre 2016 Información / Information

Anestesiología y Medicina del Dolor 52 664 6848905 vwhizar@anestesia-dolor.org anestesia-dolor.org Copyright © 2015

Trauma pediátrico / Pediatric trauma

Octubre 4, 2016. No. 2468

Manejo del trauma pediátrico Management of Pediatric Trauma. COMMITTEE ON PEDIATRIC EMERGENCY MEDICINE, COUNCIL ON INJURY; VIOLENCE, AND POISON PREVENTION, SECTION ON CRITICAL CARE, SECTION ON ORTHOPAEDICS, SECTION ON SURGERY, SECTION ON TRANSPORT MEDICINE, PEDIATRIC TRAUMA SOCIETY, AND SOCIETY OFTRAUMA NURSES PEDIATRIC COMMITTEE. Pediatrics. 2016 Aug;138(2). pii: e20161569. doi: 10.1542/peds.2016-1569. Abstract Injury is still the number 1 killer of children ages 1 to 18 years in the United States (http://www.cdc.gov/nchs/fastats/children.htm). Children who sustain injuries with resulting disabilities incur significant costs not only for their health care but also for productivity lost to the economy. The families of children who survive childhood injury with disability face years of emotional and financial hardship, along with a significant societal burden. The entire process of managing childhood injury is enormously complex and varies by region. Only the comprehensive cooperation of a broadly diverse trauma team will have a significant effect on improving the care of injured children. PDF XIII Congreso Virtual Mexicano de Anestesiología Octubre a Diciembre 2016 Información / Information

Anestesiología y Medicina del Dolor 52 664 6848905 vwhizar@anestesia-dolor.org anestesia-dolor.org Copyright © 2015